Publications by authors named "Sabrina Digiovanni"

Claim this Profile
I
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy.
Sofia La Vecchia, Simona Fontana, Iris Chiara Salaroglio, Dario Pasquale Anobile, Sabrina Digiovanni

Cancer Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.
Sabrina Digiovanni, Martina Lorenzati, Olga Teresa Bianciotto, Martina Godel, Simona Fontana

Fluids Barriers CNS· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting pentamidine towards CD44-overexpressing cells using hyaluronated lipid-polymer hybrid nanoparticles.
Ilaria Andreana, Marta Chiapasco, Valeria Bincoletto, Sabrina Digiovanni, Maela Manzoli

Drug Deliv Transl Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, Martina Godel, Francesca Napoli, Sabrina Digiovanni

J Exp Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, Martina Godel, Francesca Napoli, Sabrina Digiovanni

J Exp Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle.
Miriam Mistretta, Veronica Fiorito, Anna Lucia Allocco, Giorgia Ammirata, Myriam Y Hsu, Sabrina Digiovanni

Cell Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Iris C Salaroglio, Dimas Carolina Belisario, Muhlis Akman, Sofia La Vecchia, Martina Godel, Sabrina Digiovanni

J Exp Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
Iris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, Preeta Ananthanarayanan, Luisa Ricci, Sabrina Digiovanni

J Exp Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis